Immune Response to Ovarian and other gynaecological Cancers (IROC) Biobank, Canada

Registration Status: Completed

Objective: Immune Response to Ovarian and other gynecological Cancers (IROC) biobank is leading to a better understanding of the immune response to ovarian cancer and other gynecological cancers. The findings from this study are helping us design new immune-based treatments for these diseases.

Registered Biobank Name Immune Response to Ovarian and other gynaecological Cancers (IROC) Biobank
Biobank Leader David Bond
Country Canada
Email for biobank inquiries david.bond@bccancer.bc.ca
Principal Investigator Brad Nelson
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Oligo - Collection aimed at supporting several research projects, a research group or a research consortium
Biospecimen Collected: